PFM Health Sciences’s Cirrus Logic CRUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,125,349
Closed -$43.4M 100
2018
Q3
$43.4M Buy
1,125,349
+368,803
+49% +$15.3M 0.64% 60
2018
Q2
$29M Buy
+756,546
New +$28.9M 0.45% 78
2017
Q2
Sell
-183,100
Closed -$11.1M 95
2017
Q1
$11.1M Sell
183,100
-294,977
-62% -$16.8M 0.28% 81
2016
Q4
$27M Sell
478,077
-74,211
-13% -$4.11M 0.76% 48
2016
Q3
$29.4M Sell
552,288
-813,791
-60% -$39.1M 0.86% 47
2016
Q2
$53M Buy
1,366,079
+1,098,706
+411% +$39.4M 1.6% 24
2016
Q1
$9.73M Buy
+267,373
New +$8.67M 0.3% 68

Other funds holding CRUS

PFM Health Sciences's CRUS Position: Q4 2018 in Review

PFM Health Sciences sold out of Cirrus Logic (CRUS) in Q4 2018, closing a stake of 1,125,349 shares — an estimated $43.4M sold.

PFM Health Sciences first reported a position in CRUS in Q1 2016 and held it in 7 quarters. The position peaked at $53M in Q2 2016. 259 funds tracked by Wall St. Rank hold CRUS as of Q4 2018.

  • PFM Health Sciences reported no remaining Cirrus Logic position as of Q4 2018 after selling out during the quarter.
  • PFM Health Sciences sold 1,125,349 Cirrus Logic shares in Q4 2018, an estimated $43.4M.
  • PFM Health Sciences first reported a position in Cirrus Logic in Q1 2016 and held it in 7 quarters.
  • PFM Health Sciences's Cirrus Logic position peaked at $53M in Q2 2016.
  • 259 funds tracked by Wall St. Rank held Cirrus Logic as of Q4 2018.

Based on PFM Health Sciences's 13F filing for Q4 2018, filed 14 Feb 2019.